Population-based study of short- and long-term survival from colorectal cancer in Denmark, 1977-1999

British Journal of Surgery

Volumn 92, Issue 7, 2005, Pages 873-880

  Iversen, L H ^a   Pedersen, L ^a   Riis, A ^a   Friis, S ^b   Laurberg, S ^a   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHILD; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; EUROPE; FEMALE; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; SEX DIFFERENCE; SURVIVAL TIME; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 21844442627     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4978     Document Type: Article

References (37)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33.
2. Sant M, Capocaccia R, Verdecchia A, Gatta G, Micheli A, Mariotto A et al. Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer 1995; 63: 43-48.
3. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47: 533-538.
4. Gatta G, Capocaccia R, Coleman MP, Gloeckler Ries LA, Hakulinen TA, Micheli A et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000; 89: 893-900.
5. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Moller TR, Storm HH et al. Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.
6. Sackett DL, Haynes RB, Tugwell P, Guyatt GH, (eds). Clinical Epidemiology: a Basic Science for Clinical Medicine (2nd edn). Little, Brown: Boston, 1991.
7. Hole DJ, McArdle CS. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg 2002; 89: 586-590.
8. Coleman MP, Rachet B, Woods LM, Mitry E, Riga M, Cooper N et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90: 1367-1373.
9. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371.
10. Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L. Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ 2004; 171: 461-465.
11. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471.
12. Danish Society of Surgery. Guidelines for the Diagnosis and the Management of Colorectal Cancer (Danish). The Danish Medical Association: Copenhagen, 1998.
13. Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; i: 1479-1482.
14. National Board of Health, Health Statistics. Cancer Incidence in Denmark 1999. National Board of Health: Copenhagen, 2003.
15. Glimelius B, Cedermark B, Dahl O, Tveit KM, Jakobsen A, Bentzen SM. Adjuvant chemotheraphy in colorectal cancer: joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Eur J Cancer 2003; 1(Suppl 5): S318-S319.
16. Carstensen B. Survival of Danish cancer patients 1943-1987. Material and methods. APMIS Suppl 1993; 33: 3-8.
17. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
18. Frank L. When an entire country is a cohort. Science 2000; 287: 2398-2399.
19. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-1608.
20. Wiggers T, Arends JW, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988; 31: 33-41.
21. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990; 33: 610-614.
22. Hughes KS, Rosenstein RB, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 1988; 31: 1-4.
23. Balslev I, Pedersen M, Teglbjærg PS, Sørensen FH, Bone J, Jacobsen NO et al. Prognosis in synchronous liver metastasis from colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the rectosigmoid colon. Ugeskr Laeger 1989; 151: 1045-1048.
24. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-358.
25. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (FMPACT) investigators. Lancet 1995; 345: 939-944.
26. Midgley RS, Kerr DJ. ABC of colorectal cancer: adjuvant therapy. BMJ 2000; 321: 1208-1211.
27. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
28. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993; 306: 752-755.
29. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000; 321: 531-535.
30. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 2002; 51: 60-64.
31. Hodgson DC, Zhang W, Zaslavsky AM, Fuchs CS, Wright WE, Ayanian JZ. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst 2003; 95: 708-716.
32. Zingmond D, Maggard M, O'Connell J, Liu J, Etzioni, Ko C. What predicts serious complications in colorectal cancer resection? Am Surg 2003; 69: 969-974.
33. Schrag D, Panageas KS, Riedel E, Hsieh L, Bach PB, Guillem JG et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003; 83: 68-78.
34. Smith JA, King PM, Lane RH, Thompson MR. Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 2003; 90: 583-592.
35. Sant M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 1659-1667.
36. Storm HH, Dickman PW, Engeland A, Haldorsen T, Hakulinen T. Do morphology and stage explain the inferior lung cancer survival in Denmark? Enr Respir J 1999; 13: 430-435.
37. Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001; 85: 367-371.